Newly identified yeast could prevent fungal infections by outcompeting rivals, study suggests

Researchers at the Weizmann Institute of Science in Israel have identified a yeast that could be used to prevent invasive candidiasis, a major cause of death in hospitalized and immunocompromised patients. The study, to be published March 18 in the Journal of Experimental Medicine (JEM), shows that the novel yeast lives harmlessly in the intestines of mice and humans and can displace the yeast responsible for candidiasis, Candida albicans.

Clear Labs to Lead Session on Whole Genome Sequencing at AACC Annual Scientific Meeting in Chicago

Clear Labs harnesses the power of next-generation sequencing (NGS) to simplify complex workflows for clinical and applied markets. By creating a fully automated platform that brings together DNA sequencing, robotics and cloud-based analytics, Clear Labs liberates genomics to deliver increased clarity. Clear Labs’ turnkey platform accelerates outcomes and improves accuracy for detection and surveillance of infectious diseases. With a novel approach, Clear Labs is helping the world better understand, track and mitigate tomorrow’s novel pathogens.

Hospital patients can do their part in COVID-19 fight

A clinical researcher, who has studied the lack of hygiene practices among hospital patients, is urging not just hospitals—but those who end up there—to do more to fight against the novel coronavirus, which had infected more than 2 million people worldwide by mid-April.